Stay Connected.
Get the inside scoop on company and product news. Subscribe to PBInsider, our quarterly e-newsletter, today!
Factor VIII Inhibitor Kit
Diagnostic KitsThe CRYOcheck™ Factor VIII Inhibitor Kit contains standardized components and a validated procedure to prepare patient samples for performing a modified Nijmegen-Bethesda assay (MNBA) as per the U.S. Centers for Disease Control and Prevention (CDC) recommendation.*
It is ideal for laboratories seeking to standardize sample preparation to limit variability in their MNBA.
- Each kit contains five vial sets, including positive and negative FVIII inhibitor controls
- Excellent repeatability and reproducibility; suitable for multi-center clinical studies
- Excellent linearity across a broad reportable range
- Convenient frozen format—ready to use within minutes, no reconstitution errors
* Miller CH, Platt SJ, Rice AS, Kelly F, Soucie JM, the Hemophilia Inhibitor Research Study Investigators. Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance. J Thromb Haemost 2012; 10: 1055–1061.
Did you know our subsidiary Affinity Biologicals offers factor VIII and factor IX inhibitor plasmas? Learn more.
Specifications
Storage and Shelf Life
Storing
below -70°C
Type
Frozen
Expiration
3 years after manufacturing date
Available Formats
| Cat # | Format |
|---|---|
| CCIK08 |
10 x 1.5 mL (IB-PNP) 10 x 1.5 mL (IB-BSA) 5 x 0.5 mL (Neg Control) 5 x 0.5 mL (Pos Control) |
US, Canada, EU, UK, Australia, and New Zealand
Webinar
Update on Factor VIII Inhibitor TestingLearn about FVIII inhibitor testing with Connie H. Miller PhD, former director of the CDC Hemostasis Lab, and Ian Burns, Senior Product Manager, Precision BioLogic.